MedPath

Effects of SGLT2 inhibitor on insulin resistance possbly through the amelioration of glucose toxicity

Not Applicable
Conditions
type 2 diabetes mellitus
Registration Number
JPRN-UMIN000029064
Lead Sponsor
Division of Endocrinology and Metabolism, Faculty of Internal Medicine, Kurume University Shcool of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are treated by insulin, and who have severe acute metabolic disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath